Global Market for Erythropoietin: 2015-2020
Report Code: PHAM-15-03.

This market research report explain current market for erythropoietin drugs in terms of value. The report also highlights the major drivers and challenges, including their profiles related to erythropoietin drugs.

The global market for erythropoietin drugs has been growing at a CAGR (2015 to 2020) of 1.0% driven by the increasing cases of anemia particularly in kidney diseases and cancer globally.

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach $7.8 billion in 2020.

The major players in the biologic erythropoietin drug market are, Amgen, Inc., Johnson & Johnson and Hoffmann-LA Roche.  Sandoz (subsidiary of Novartis International AG), Hospira (subsidiary of Pfizer, Inc.), Biocon, Biosidus, 3SBio, are some of the major biosimilar players across regions. 

 

$4,800.00


"Get Notified On all out New and Upcoming Reports"

       on all the latest research reports

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach $7.8 billion in 2020.

The major players in the erythropoietin market are Amgen Inc., Dr. Reddys Labs Ltd, Biocon (India) Ltd, Roche, Zydus Cadila Healthcare Ltd, Johnson & Johnson, Ranbaxy Laboratories Ltd, Shantha Biotechnics Pvt Ltd and Emcure Pharmaceuticals Ltd. The “Global market for erythropoietin, 2020” discusses the following aspects of global erythropoietin market.

  • Global erythropoietin market size, share & forecast
  • Segmental analysis of erythropoietin, by type, by application and region.
  • Competitive vendor’s landscape and company SWOT analysis.
   

Title

Pages

Price

Cart

BUY FULL REPORT

110

$4800

Buy-Now

CHAPTER: ONE  

INTRODUCTION
OBJECTIVES
SCOPE
DATA SOURCES
DISCLAIMER

4

Exempt

Buy-Now

CHAPTER: TWO

SUMMARY

3

$150

Buy-Now

CHAPTER: THREE

OVERVIEW

DEFINITION

EPO DRUG BY TYPE

BIOLOGICS

Epoietin-alfa

Epoietin-beta

Darbepoietin-alfa

Others

BIOSIMILARS

Epoietin-zeta

Epoietin-omega

Others

APPLICATION

End stage renal disease

Pre-dialysis

Oncology

Others

SIBE EFFECTS OF ERYTHROPOIETIN

5

$250

Buy-Now

CHAPTER: FOUR

FORECASTING

GLOBAL ERYTHROPOIETIN MARKET

Global EPO Biologics Drugs

Global EPO Biosimilars Drugs

EPO BIOLOGIC DRUG MARKET BY TYPE

Epoietin-alfa

Epoietin-beta

Darbepoietin-alfa

Others

EPO BIOLOGIC MARKET BY DRUG

Epogen

Procrit

Eprex

Mircera

NeoRecromon

Aranesp

Others

EPO BIOSIMILAR MARKET BY DRUG

Retacrit

Binocrit

Abseamed

EPIAO

HEMAX

Epoetin-alfa BS

Xue Da Sheng

Others

EPO BIOSIMILARS DRUG MARKET BY TYPE

Epoetin-zeta

Epoetin-omega

Others

EPO DRUG MARKET BY HALF LIFE

Long Acting EPO

Short Acting EPO

GLOBAL ERYTHROPOIETIN DRUG MARKET BY APPLICATION

End Stage Renal Disease (ESRD)

Oncology Diseases

Pre-dialysis

Others

GLOBAL ERYTHROPOEITIN MARKET SEGMENTATION, BY GEOGRAPHY

North America

Europe

Asia pacific

South America

ROW

GLOBAL ERYTHROPOEITIN NORTH AMERICAN MARKET SUB-SEGMENTATION

U.S

Mexico

Canada

GLOBAL ERYTHROPOEITIN EUROPE MARKET SUB-SEGMENTATION

EU-5

Nordic

Russia

Others

GLOBAL ERYTHROPOEITIN ASIA-PACIFIC MARKET SUB-SEGMENTATION

China

India

Japan

Australia

Others

GLOBAL ERYTHROPOEITIN SOUTH AMERICAN MARKET SUB-SEGMENTATION

Brazil

Argentina

Others

11

$3000

Buy-Now

CHAPTER: FIVE

PATENTS AND R & D PIPELINE

11

$150

Buy-Now

CHAPTER: SIX

DRIVERS

INCREASING CASES ESRD

GLOBAL DIALYSIS PATIENT POPULATION

INCREASING PREVALENCE OF CANCER

UPCOMING PATENT EXPIRIES OF ORIGINAL BIO DRUGS

33

$500

Buy-Now

CHAPTER: SEVEN

CHALLENGES

INCREASING CONCERNS OVER RISK OF THROMBOSIS AND PRCA

INCREASING COMPETITION FROM OTHER ALTERNATIVE DRUGS

15

$250

Buy-Now

CHAPTER: EIGHT

SUPPLIERS LANDSCAPE AND COMPANY PROFILES
SUPPLIER LANDSCAPE
COMPANY PROFILES

3S BIO

AMEGA BIOTECH

AMGEN

APPOLLO PHARMACEUTICALS

ASTRA ZENECA

BEIJING SIHUAN

BIOCON (INDIA)

BIOSIDUS

BLAUSEIGEL

CENTER OF MOLECULAR IMMUNOLOGY

CELON LABS

CHALVER LABORATORIES

CHENDU DIAO

CJ HEALTH CARE

CLARIS LIFESCIENCES

CRYOPHARMA

DR. REDDYS LABS

EBIOSCIENCE

ETHNOR

EMCURE PHARMACEUTICALS

FERON LIFESCIENCES

HAYAO BIOLOGICAL

HINDUSTAN ANTIBIOTICS

HOSPIRA

INCEPTA PHARMACEUTICALS

INTAS PHARMACEUTICALS

JCR PHARMA

JOHNSON & JOHNSON

KISSEI PHARMACEUTICAL

KLARVOYANT BIOGENICS

KYOWA HAKKO

LANDSTEINER

LA RENON HEALTHCARE

LG LIFE SCIENCES INDIA

LUPIN

MEDICE ARZNEIMITTEL

MICRO LABS

NANOGEN BIOPHARMACEUTICAL

NOVARTIS

PANACEA BIOTEC

PISA

PROBIOMED

RELIANCE FORMULATION

ROCHE

RPG LIFE SCIENCES

SEPTALYST LIFESCIENCES

SERUM INSTITUTE OF INDIA

SHANDONG KEXING BIOPRODUCTS

SHANGHAI CHEMO

SHANTHA BIOTECHNICS

STADA ARZENEIMITTEL

SUN PHARMACEUTICALS

TAJ PHARMACEUTICALS

TEVA

VHB LIFE SCIENCES

VIFOR PHARMA

WOCKHARDT

ZUVENTUS HEALTH CARE

ZYDUS CADILA HEALTHCARE

34

$1500

Buy-Now

LIST OF TABLES

SUMMARY TABLE VALUE FORECAST – GLOBAL EPO DRUG MARKET BY REGION 2015-2020 ($ MILLIONS)

TABLE: 01 VALUE FORECAST: GLOBAL EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 02 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY CATEGORY, THROUGH 2020 ($ MILLIONS)

TABLE: 03 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 04 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 05 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)

TABLE: 06 VALUE FORECAST: GLOBAL EPO BIOLOGICS DRUG MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)

TABLE: 07 VALUE FORECAST: GLOBAL EPO BIOSIMILARS DRUG MARKET BY TYPE, THROUGH 2020 ($ MILLIONS)

TABLE: 08 VALUE FORECAST: GLOBAL EPOETIN-ALFA DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 09 VALUE FORECAST: GLOBAL EPOETIN-BETA DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 10 VALUE FORECAST: GLOBAL DARBEPOETIN-ALFA DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 11 VALUE FORECAST: GLOBAL OTHER EPO BIOLOGICS DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 12 VALUE FORECAST: GLOBAL EPOETIN-ALFA DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 13 VALUE FORECAST: GLOBAL EPOETIN-BETA DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 14 VALUE FORECAST: GLOBAL DARBEPOETIN-ALFA DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 15 VALUE FORECAST: GLOBAL OTHER BIOLOGIC DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 16 VALUE FORECAST: GLOBAL BIOLOGIC MARKET BY DRUG, THROUGH 2020 ($ MILLIONS)

TABLE: 17 VALUE FORECAST: GLOBAL EPOGEN DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 18 VALUE FORECAST: GLOBAL EPOGEN DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 19 VALUE FORECAST: GLOBAL PROCRIT DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 20 VALUE FORECAST: GLOBAL PROCRIT DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 21 VALUE FORECAST: GLOBAL EPREX DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 22 VALUE FORECAST: GLOBAL EPREX DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 23 VALUE FORECAST: GLOBAL ARANESP DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 24 VALUE FORECAST: GLOBAL ARANESP DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 25 VALUE FORECAST: GLOBAL NEORECORMON DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 26 VALUE FORECAST: GLOBAL NEORECORMON DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 27 VALUE FORECAST: GLOBAL MIRCERA DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 28 VALUE FORECAST: GLOBAL MIRCERA DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 29 VALUE FORECAST: GLOBAL EPOETIN-ZETA DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 30 VALUE FORECAST: GLOBAL EPOETIN-OMEGA DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 31 VALUE FORECAST: GLOBAL OTHER EPO BIOSIMILARS DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 32 VALUE FORECAST: GLOBAL EPOETIN-ZETA DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 33 VALUE FORECAST: GLOBAL EPOETIN-OMEGA DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 34 VALUE FORECAST: GLOBAL OTHER BIOSIMILARS DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 35 VALUE FORECAST: GLOBAL BIOSIMILARS MARKET BY DRUG, THROUGH 2020 ($ MILLIONS)

TABLE: 36 VALUE FORECAST: GLOBAL RETACRIT DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 37 VALUE FORECAST: GLOBAL RETACRIT DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 38 VALUE FORECAST: GLOBAL BINOCRIT DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 39 VALUE FORECAST: GLOBAL BINOCRIT DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 40 VALUE FORECAST: GLOBAL ABSEAMED DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 41 VALUE FORECAST: GLOBAL ABSEAMED DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 42 VALUE FORECAST: GLOBAL EPIAO DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 43 VALUE FORECAST: GLOBAL EPIAO DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 44 VALUE FORECAST: GLOBAL HEMAX DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 45 VALUE FORECAST: GLOBAL HEMAX DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 46 VALUE FORECAST: GLOBAL EPOETIN-ALFA BS DRUG MARKETBY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 47 VALUE FORECAST: GLOBAL EPOETIN-ALFA BS DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 48 VALUE FORECAST: GLOBAL XUE DA SHENG DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 49 VALUE FORECAST: GLOBAL XUE DA SHENG DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 50 VALUE FORECAST: GLOBAL BINOCRIT DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 51 VALUE FORECAST: GLOBAL BINOCRIT DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 52 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY HALF-LIFE, THROUGH 2020 ($ MILLIONS)

TABLE: 53 VALUE FORECAST: GLOBAL LONG ACTING EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 54 VALUE FORECAST: GLOBAL SHORT ACTING EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 55 VALUE FORECAST: GLOBAL LONG ACTING EPO DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 56 VALUE FORECAST: GLOBAL SHORT ACTING EPO DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 57 VALUE FORECAST: GLOBAL LONG ACTING EPO DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 58 VALUE FORECAST: GLOBAL SHORT ACTING EPO DRUG MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)

TABLE: 59 VALUE FORECAST: GLOBAL EPO BIOLOGICS DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 60 VALUE FORECAST: GLOBAL EPO BIOSIMILARS DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS)

TABLE: 61 VALUE FORECAST: GLOBAL END STAGE RENAL DISEASE (ESRD) APPLICATION DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 62 VALUE FORECAST: GLOBAL PRE-DIALYSIS APPLICATION DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 63 VALUE FORECAST: GLOBAL ONCOLOGY APPLICATION DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 64 VALUE FORECAST: GLOBAL OTHER APPLICATION DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 65 VALUE FORECAST: GLOBAL EPO BIOLOGICS DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 66 VALUE FORECAST: GLOBAL EPO BIOSIMILARS DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS)

TABLE: 67 VALUE FORECAST: NORTH AMERICA EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 68 VALUE FORECAST: NORTH AMERICA EPO BIOLOGIC DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 69 VALUE FORECAST: NORTH AMERICA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 70 VALUE FORECAST: MEXICO EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 71 VALUE FORECAST: EUROPE EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 72 VALUE FORECAST: EUROPE EPO BIOLOGIC DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 73 VALUE FORECAST: EUROPE EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 74 VALUE FORECAST: GERMANY EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 75 VALUE FORECAST: ITALY EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 76 VALUE FORECAST: FRANCE EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 77 VALUE FORECAST: SPAIN EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 78 VALUE FORECAST: U.K. EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 79 VALUE FORECAST: NORDIC EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 80 VALUE FORECAST: RUSSIA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 81 VALUE FORECAST: OTHER EUROPEAN EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 82 VALUE FORECAST: ASIA-PACIFIC EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 83 VALUE FORECAST: ASIA-PACIFIC EPO BIOLOGIC DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 84 VALUE FORECAST: ASIA-PACIFIC EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 85 VALUE FORECAST: CHINA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 86 VALUE FORECAST: INDIA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 87 VALUE FORECAST: JAPAN EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 88 VALUE FORECAST: AUSTRALIA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 89 VALUE FORECAST: OTHER ASIA-PACIFIC EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 90 VALUE FORECAST: SOUTH AMERICA EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 91 VALUE FORECAST: SOUTH AMERICA EPO BIOLOGIC DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 92 VALUE FORECAST: SOUTH AMERICA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 93 VALUE FORECAST: BRAZIL EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 94 VALUE FORECAST: ARGENTINA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 95 VALUE FORECAST: OTHER SOUTH AMERICA EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 96 VALUE FORECAST: ROW EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 97 VALUE FORECAST: ROW EPO BIOLOGIC DRUG MARKET, THROUGH 2020 ($ MILLIONS)

TABLE: 98 VALUE FORECAST: ROW EPO BIOSIMILAR DRUG MARKET, THROUGH 2020 ($ MILLIONS)

$2000

Buy-Now

LIST OF FIGURES

SUMMARY CHART VALUE FORECAST: GLOBAL EPO DRUG MARKET BY REGION 2015-2020 ($ MILLIONS)

FIGURE: 01 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 02 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY CATEGORY, 2015 AND 2020 (%)

FIGURE: 03 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 04 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 05 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY TYPE, 2015 AND 2020 (%)

FIGURE: 06 MARKET SHARE BY VALUE: GLOBAL EPO BIOLOGICS DRUG MARKET BY TYPE, 2015 AND 2020 (%)

FIGURE: 07 MARKET SHARE BY VALUE: GLOBAL EPO BIOSIMILARS DRUG MARKET BY TYPE, 2015 AND 2020 (%)

FIGURE: 08 MARKET SHARE BY VALUE: GLOBAL EPOETIN-ALFA DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 09 MARKET SHARE BY VALUE: GLOBAL EPOETIN-BETA DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 10 MARKET SHARE BY VALUE: GLOBAL DARBEPOETIN-ALFA DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 11 MARKET SHARE BY VALUE: GLOBAL OTHER EPO BIOLOGICS DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 12 MARKET SHARE BY VALUE: GLOBAL EPOETIN-ALFA DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 13 MARKET SHARE BY VALUE: GLOBAL EPOETIN-BETA DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 14 MARKET SHARE BY VALUE: GLOBAL DARBEPOETIN-ALFA DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 15 MARKET SHARE BY VALUE: GLOBAL OTHER BIOLOGIC DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 16 MARKET SHARE BY VALUE: GLOBAL BIOLOGIC MARKET BY DRUG, 2015 AND 2020 (%)

FIGURE: 17 MARKET SHARE BY VALUE: GLOBAL EPOGEN DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 18 MARKET SHARE BY VALUE: GLOBAL EPOGEN DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 19 MARKET SHARE BY VALUE: GLOBAL PROCRIT DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 20 MARKET SHARE BY VALUE: GLOBAL PROCRIT DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 21 MARKET SHARE BY VALUE: GLOBAL EPREX DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 22 MARKET SHARE BY VALUE: GLOBAL EPREX DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 23 MARKET SHARE BY VALUE: GLOBAL ARANESP DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 24 MARKET SHARE BY VALUE: GLOBAL ARANESP DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 25 MARKET SHARE BY VALUE: GLOBAL NEORECORMON DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 26 MARKET SHARE BY VALUE: GLOBAL NEORECORMON DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 27 MARKET SHARE BY VALUE: GLOBAL MIRCERA DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 28 MARKET SHARE BY VALUE: GLOBAL MIRCERA DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 29 MARKET SHARE BY VALUE: GLOBAL EPOETIN-ZETA DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 30 MARKET SHARE BY VALUE: GLOBAL EPOETIN-OMEGA DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 31 MARKET SHARE BY VALUE: GLOBAL OTHER EPO BIOSIMILARS DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 32 MARKET SHARE BY VALUE: GLOBAL EPOETIN-ZETA DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 33 MARKET SHARE BY VALUE: GLOBAL EPOETIN-OMEGA DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 34 MARKET SHARE BY VALUE: GLOBAL OTHER BIOSIMILARS DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 35 MARKET SHARE BY VALUE: GLOBAL BIOSIMILARS MARKET BY DRUG, 2015 AND 2020 (%)

FIGURE: 36 MARKET SHARE BY VALUE: GLOBAL RETACRIT DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 37 MARKET SHARE BY VALUE: GLOBAL RETACRIT DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 38 MARKET SHARE BY VALUE: GLOBAL BINOCRIT DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 39 MARKET SHARE BY VALUE: GLOBAL BINOCRIT DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 40 MARKET SHARE BY VALUE: GLOBAL ABSEAMED DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 41 MARKET SHARE BY VALUE: GLOBAL ABSEAMED DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 42 MARKET SHARE BY VALUE: GLOBAL EPIAO DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 43 MARKET SHARE BY VALUE: GLOBAL EPIAO DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 44 MARKET SHARE BY VALUE: GLOBAL HEMAX DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 45 MARKET SHARE BY VALUE: GLOBAL HEMAX DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 46 MARKET SHARE BY VALUE: GLOBAL EPOETIN-ALFA BS DRUG MARKETBY REGION, 2015 AND 2020 (%)

FIGURE: 47 MARKET SHARE BY VALUE: GLOBAL EPOETIN-ALFA BS DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 48 MARKET SHARE BY VALUE: GLOBAL XUE DA SHENG DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 49 MARKET SHARE BY VALUE: GLOBAL XUE DA SHENG DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 50 MARKET SHARE BY VALUE: GLOBAL BINOCRIT DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 51 MARKET SHARE BY VALUE: GLOBAL BINOCRIT DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 52 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY HALF-LIFE, 2015 AND 2020 (%)

FIGURE: 53 MARKET SHARE BY VALUE: GLOBAL LONG ACTING EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 54 MARKET SHARE BY VALUE: GLOBAL SHORT ACTING EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 55 MARKET SHARE BY VALUE: GLOBAL LONG ACTING EPO DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 56 MARKET SHARE BY VALUE: GLOBAL SHORT ACTING EPO DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 57 MARKET SHARE BY VALUE: GLOBAL LONG ACTING EPO DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 58 MARKET SHARE BY VALUE: GLOBAL SHORT ACTING EPO DRUG MARKET BY APPLICATION, 2015 AND 2020 (%)

FIGURE: 59 MARKET SHARE BY VALUE: GLOBAL EPO BIOLOGICS DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 60 MARKET SHARE BY VALUE: GLOBAL EPO BIOSIMILARS DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%)

FIGURE: 61 MARKET SHARE BY VALUE: GLOBAL END STAGE RENAL DISEASE (ESRD) APPLICATION DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 62 MARKET SHARE BY VALUE: GLOBAL PRE-DIALYSIS APPLICATION DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 63 MARKET SHARE BY VALUE: GLOBAL ONCOLOGY APPLICATION DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 64 MARKET SHARE BY VALUE: GLOBAL OTHER APPLICATION DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 65 MARKET SHARE BY VALUE: GLOBAL EPO BIOLOGICS DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 66 MARKET SHARE BY VALUE: GLOBAL EPO BIOSIMILARS DRUG MARKET BY REGION, 2015 AND 2020 (%)

FIGURE: 67 MARKET SHARE BY VALUE: NORTH AMERICA EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 68 MARKET SHARE BY VALUE: NORTH AMERICA EPO BIOLOGIC DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 69 MARKET SHARE BY VALUE: NORTH AMERICA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 70 MARKET SHARE BY VALUE: MEXICO EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 71 MARKET SHARE BY VALUE: EUROPE EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 72 MARKET SHARE BY VALUE: EUROPE EPO BIOLOGIC DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 73 MARKET SHARE BY VALUE: EUROPE EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 74 MARKET SHARE BY VALUE: GERMANY EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 75 MARKET SHARE BY VALUE: ITALY EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 76 MARKET SHARE BY VALUE: FRANCE EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 77 MARKET SHARE BY VALUE: SPAIN EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 78 MARKET SHARE BY VALUE: U.K. EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 79 MARKET SHARE BY VALUE: NORDIC EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 80 MARKET SHARE BY VALUE: RUSSIA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 81 MARKET SHARE BY VALUE: OTHER EUROPEAN EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 82 MARKET SHARE BY VALUE: ASIA-PACIFIC EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 83 MARKET SHARE BY VALUE: ASIA-PACIFIC EPO BIOLOGIC DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 84 MARKET SHARE BY VALUE: ASIA-PACIFIC EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 85 MARKET SHARE BY VALUE: CHINA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 86 MARKET SHARE BY VALUE: INDIA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 87 MARKET SHARE BY VALUE: JAPAN EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 88 MARKET SHARE BY VALUE: AUSTRALIA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 89 MARKET SHARE BY VALUE: OTHER ASIA-PACIFIC EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 90 MARKET SHARE BY VALUE: SOUTH AMERICA EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 91 MARKET SHARE BY VALUE: SOUTH AMERICA EPO BIOLOGIC DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 92 MARKET SHARE BY VALUE: SOUTH AMERICA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 93 MARKET SHARE BY VALUE: BRAZIL EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 94 MARKET SHARE BY VALUE: ARGENTINA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 95 MARKET SHARE BY VALUE: OTHER SOUTH AMERICA EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 96 MARKET SHARE BY VALUE: ROW EPO DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 97 MARKET SHARE BY VALUE: ROW EPO BIOLOGIC DRUG MARKET, 2015 AND 2020 (%)

FIGURE: 98 MARKET SHARE BY VALUE: ROW EPO BIOSIMILAR DRUG MARKET, 2015 AND 2020 (%)

$1500

Buy-Now

This market research report explain current market for erythropoietin drugs in terms of value. The report also highlights the major drivers and challenges, including their profiles related to erythropoietin drugs.

The global market for erythropoietin drugs has been growing at a CAGR (2015 to 2020) of 1.0% driven by the increasing cases of anemia particularly in kidney diseases and cancer globally.

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach $7.8 billion in 2020.

SUMMARY TABLE 

VALUE FORECAST - GLOBAL ERYTHROPOIETIN DRUG MARKET BY REGION 2015-2020

($ MILLIONS)

summary Image

Source: Ceskaa Research